Fluctuations in blood pressure over an extended period, along with their interaction with mean blood pressure or intraocular pressure, are associated with a more rapid visual field progression in patients with suspected or confirmed glaucoma.
Patients with nAMD diagnosed by their family doctor or general practitioner had a threefold higher risk for nonadherence than those diagnosed by the physician treating their nAMD.
In 2022, an estimated 4.22 million people in the United States had glaucoma, with a prevalence of 1.62% and 2.56% among all adults and those aged 40 years or older, respectively.
50-60% of patients with Myasthenia Gravis present initially with only ocular symptoms, droopy eyelids, double vision, weakness at closing the eyes
Of three blood metabolites, hypoxanthine may act as a potential free radical generator and an indicator of hypoxic conditions.
Both anti-VEGF and surgery treat SMH in AMD with similar VA outcomes but different safety profiles. Anti-VEGF is preferred for less severe hemorrhage, whereas surgery is suited for extensive hemorrhage. Despite uncertain comparative VA outcomes, treatment should be guided by clinical judgment and patient factors.
Ophthalmology Retina. Vol 9, Issue 1, Jan 2025
Shaheem A, et al
The World Health Organization (WHO) has declared mpox a global health emergency due to its spread in multiple countries, including the U.S. To protect both patients and healthcare providers, the CDC recommends using personal protective equipment (PPE) such as gloves, protective eyewear, gowns, and N95 masks. Additionally, patients with suspected mpox should be seen in isolated exam rooms, and all surfaces should be disinfected thoroughly after the visit.
Zhao, Z., et al. (2024). “Keeping an Eye Out for Mpox.” Frontiers in Medicine. Accessed September 17, 2024.
Oral micronutrients supplementation with Zinc, Copper, Vitamin C, Vitamin E, and lutein/zeaxanthin and diet, slows geographic atrophy (GA) progression toward the central macula, likely by augmenting the natural phenomenon of foveal sparing.
Two drugs have received FDA approval. Pegcetacoplan (a C3 complement inhibitor) and Avacincaptad pegol (a C5 complement inhibitor) with the limitations of been intravitreal injections, modest efficacy, side effects and cost.
GA is noncentral at onset in approximately two thirds of eyes. GA progression into the central macular area is substantially slower than progression in the more peripheral macula, leading to the beneficial phenomenon of foveal sparing.
Keenan T, et al. Ophthalmology 2025;132:14-29
In our practice we also include Meso-Zeaxanthin, the third pigment found in the macula.
Xanthelasma palpebrarum was not associated with increased rates of dyslipidemia or CVD. This questions the extent to which XP serves as an indicative marker for heightened systemic risk.
Lustig-Barzelai Y, et al. Ophthalmology 2025; 132 (2):164-169
myeyeconsultants.com
845 E Warner Rd, Suite 101 Chandler, Arizona 85225, United States
Copyright © 2025 myeyeconsultants.com - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.